Adjusted logistic regression models of parameters associated with PLEX outcomes
OR (95% CI) | p Value | GOF | |
Complete improvement | |||
Sex (male vs female) | 3.2 (0.8 to 12.9) | 0.11 | 0.28 |
Basal impairment | 2.4 (1.0 to 5.8) | 0.05 | |
PLEX delay | pglobal=0.01 | ||
Days 0–5 versus ≥day 11 | 5.3 (1.8 to 15.9) | <0.01 | |
Days 6–10 versus ≥day 11 | 2.5 (0.8 to 8.2) | 0.12 | |
Highest third improvement | |||
Type | 2.0 (0.9 to 4.5) | 0.10 | 0.43 |
Residence (foreign vs local) | 0.4 (0.2 to 0.9) | 0.03 | |
PLEX delay | pglobal=0.10 | ||
Days 0–5 versus ≥day 11 | 2.8 (1.1 to 7.3) | 0.04 | |
Days 6–10 versus ≥day 11 | 1.9 (0.7 to 5.1) | 0.20 | |
Lower third improvement | |||
Residence (foreign vs local) | 2.3 (1.0 to 5.2) | 0.04 | 0.44 |
PLEX delay | pglobal=0.29 | ||
Days 0–5 versus ≥day 11 | 0.44 (0.2 to 1.2) | 0.12 | |
Days 6–10 versus ≥day 11 | 0.6 (0.2 to 1.8) | 0.39 |
GOF, goodness of fit; PLEX, plasma exchange.